Cabot (NYSE:CBT) Issues FY25 Earnings Guidance

Cabot (NYSE:CBTGet Free Report) updated its FY25 earnings guidance on Monday. The company provided earnings per share guidance of $7.40-7.80 for the period, compared to the consensus earnings per share estimate of $7.85. Cabot also updated its FY 2025 guidance to 7.400-7.800 EPS.

Cabot Stock Up 1.0 %

Shares of CBT stock traded up $1.07 during mid-day trading on Monday, reaching $110.09. 709,694 shares of the company’s stock traded hands, compared to its average volume of 336,001. The company has a market cap of $6.04 billion, a P/E ratio of 13.15, a P/E/G ratio of 0.90 and a beta of 1.20. The company has a quick ratio of 1.45, a current ratio of 2.22 and a debt-to-equity ratio of 0.72. Cabot has a 12 month low of $66.02 and a 12 month high of $117.14. The company’s 50-day moving average price is $108.20 and its 200-day moving average price is $100.87.

Cabot (NYSE:CBTGet Free Report) last released its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1 billion. During the same period in the previous year, the company posted $1.42 earnings per share. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, equities analysts expect that Cabot will post 7.07 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on CBT. JPMorgan Chase & Co. increased their target price on Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a report on Wednesday, August 7th. UBS Group cut their target price on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a research report on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $101.75.

View Our Latest Report on Cabot

Insider Buying and Selling at Cabot

In other news, CFO Erica Mclaughlin sold 23,274 shares of the stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the sale, the chief financial officer now directly owns 59,814 shares of the company’s stock, valued at $5,968,839.06. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the sale, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Erica Mclaughlin sold 23,274 shares of Cabot stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the transaction, the chief financial officer now directly owns 59,814 shares in the company, valued at approximately $5,968,839.06. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 71,939 shares of company stock valued at $7,308,812 over the last 90 days. 3.07% of the stock is currently owned by corporate insiders.

Cabot Company Profile

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.